1. Home
  2. SB vs ENTA Comparison

SB vs ENTA Comparison

Compare SB & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safe Bulkers Inc ($0.001 par value)

SB

Safe Bulkers Inc ($0.001 par value)

HOLD

Current Price

$5.33

Market Cap

479.9M

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.51

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SB
ENTA
Founded
2007
1995
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.9M
407.5M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
SB
ENTA
Price
$5.33
$14.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$6.00
$20.40
AVG Volume (30 Days)
607.3K
288.8K
Earning Date
11-25-2025
11-17-2025
Dividend Yield
3.76%
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$274,661,000.00
$65,324,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
$13.74
$0.19
P/E Ratio
$14.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$4.09
52 Week High
$5.54
$15.34

Technical Indicators

Market Signals
Indicator
SB
ENTA
Relative Strength Index (RSI) 67.22 72.93
Support Level $5.20 $11.89
Resistance Level $5.54 $14.52
Average True Range (ATR) 0.16 0.86
MACD 0.03 0.10
Stochastic Oscillator 75.42 95.27

Price Performance

Historical Comparison
SB
ENTA

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: